Urmăriți
Francisco Gil-Bea
Francisco Gil-Bea
Instituto Biodonostia
Adresă de e-mail confirmată pe biodonostia.org
Titlu
Citat de
Citat de
Anul
A multicentre validation study of the diagnostic value of plasma neurofilament light
NJ Ashton, S Janelidze, A Al Khleifat, A Leuzy, EL van der Ende, ...
Nature communications 12 (1), 3400, 2021
2722021
Cholinergic–serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer’s disease
M Garcia-Alloza, FJ Gil-Bea, M Diez-Ariza, CPLH Chen, PT Francis, ...
Neuropsychologia 43 (3), 442-449, 2005
2712005
Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment
N Elizalde, FJ Gil-Bea, MJ Ramirez, B Aisa, B Lasheras, J Del Rio, ...
Psychopharmacology 199, 1-14, 2008
2312008
ALS: A bucket of genes, environment, metabolism and unknown ingredients
M Zufiria, FJ Gil-Bea, R Fernandez-Torron, JJ Poza, JL Muñoz-Blanco, ...
Progress in neurobiology 142, 104-129, 2016
2092016
Lack of localization of 5‐HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5‐HT6 receptor‐mediated acetylcholine release
B Marcos, FJ Gil‐Bea, WD Hirst, M García‐Alloza, MJ Ramírez
European Journal of Neuroscience 24 (5), 1299-1306, 2006
1362006
Cardiotrophin-1 is a key regulator of glucose and lipid metabolism
MJ Moreno-Aliaga, N Pérez-Echarri, B Marcos-Gómez, E Larequi, ...
Cell metabolism 14 (2), 242-253, 2011
1352011
Increased sensitivity to MPTP in human α-synuclein A30P transgenic mice
M Nieto, FJ Gil-Bea, E Dalfó, M Cuadrado, F Cabodevilla, B Sánchez, ...
Neurobiology of aging 27 (6), 848-856, 2006
1212006
Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit
FJ Gil-Bea, M García-Alloza, J Domínguez, B Marcos, MJ Ramírez
Neuroscience letters 375 (1), 37-41, 2005
1182005
Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease
M Garcia-Alloza, SW Tsang, FJ Gil-Bea, PT Francis, MK Lai, B Marcos, ...
Neurobiology of aging 27 (8), 1110-1117, 2006
1052006
Activity‐Regulated Cytoskeleton‐Associated Protein in Rodent Brain is Down‐Regulated by High Fat Diet in vivo and by 27‐Hydroxycholesterol in vitro
L Mateos, S Akterin, FJ Gil‐Bea, S Spulber, A Rahman, I Björkhem, ...
Brain Pathology 19 (1), 69-80, 2009
1002009
Decreased levels of guanosine 3′, 5′‐monophosphate (c GMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in A lzheimer's disease
A Ugarte, F Gil‐Bea, C García‐Barroso, Á Cedazo‐Minguez, MJ Ramírez, ...
Neuropathology and applied neurobiology 41 (4), 471-482, 2015
972015
HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease
FJ Gil-Bea, B Aisa, A Solomon, M Solas, M del Carmen Mugueta, ...
Journal of Alzheimer's disease 22 (3), 829-838, 2010
972010
Neonatal stress affects vulnerability of cholinergic neurons and cognition in the rat: involvement of the HPA axis
B Aisa, FJ Gil-Bea, B Marcos, R Tordera, B Lasheras, J Del Río, ...
Psychoneuroendocrinology 34 (10), 1495-1505, 2009
942009
Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimer's disease
FJ Gil-Bea, M Solas, A Solomon, C Mugueta, B Winblad, M Kivipelto, ...
Journal of Alzheimer's Disease 22 (2), 405-413, 2010
912010
Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease
L Mateos, MAM Ismail, FJ Gil-Bea, V Leoni, B Winblad, I Bjoerkhem, ...
Journal of Alzheimer's Disease 24 (4), 669-679, 2011
882011
Effects of 5‐HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat
B Marcos, TT Chuang, FJ Gil‐Bea, MJ Ramirez
British journal of pharmacology 155 (3), 434-440, 2008
852008
Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits
G Gerenu, E Martisova, H Ferrero, M Carracedo, T Rantamäki, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1863 (4), 991 …, 2017
812017
Increase of locomotor activity underlying the behavioral disinhibition in tg2576 mice.
FJ Gil-Bea, B Aisa, R Schliebs, MJ Ramírez
Behavioral neuroscience 121 (2), 340, 2007
802007
Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease
S Samakashvili, C Ibáñez, C Simo, FJ Gil‐Bea, B Winblad, ...
Electrophoresis 32 (19), 2757-2764, 2011
762011
Aggregation of the inflammatory S100A8 precedes Aβ plaque formation in transgenic APP mice: positive feedback for S100A8 and Aβ productions
M Lodeiro, E Puerta, MAM Ismail, P Rodriguez-Rodriguez, A Rönnbäck, ...
Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2017
712017
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20